Mack Roach III MD, FACR, FASTRO
Professor, Radiation Oncology and Urology, and Director, Particle Therapy Research Program & Outreach, Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CaliforniaRecent Contributions to PracticeUpdate:
- Secondary Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy
- Outcomes and Toxicity After Postprostatectomy Intensity-Modulated Radiation Therapy
- The Impact of Age at the Time of Radiotherapy for Localized Prostate Cancer on the Development of Second Primary Malignancies
- Stereotactic Ablative Body Radiotherapy for Oligometastatic Prostate Cancer
- Role of Adjuvant Radiotherapy for Organ-Confined Prostate Cancer With a Positive Surgical Margin
- Long-Term Outcomes After Bladder-Preserving Trimodal Therapy for Patients With Muscle-Invasive Bladder Cancer
- Long-Term Impact of Adjuvant vs Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Treated With Radical Prostatectomy
- Very Early Salvage Radiotherapy After Radical Prostatectomy Improves Distant Metastasis–Free Survival
- Patterns of Lymph Node Failure After Dose-Escalated Radiotherapy
- ADT Plus Radiotherapy Improves Survival in Older Men With Prostate Cancer